Monoclonal Antibody Therapy is a cutting-edge treatment for #COVID19 patients with mild and moderate symptoms. It can keep patients from falling critically ill, getting hospitalized, and reduces mortality rate related to COVID-19. This path-breaking treatment is a ray of hope amidst these unprecedented times. To know more about the therapy, 📞 0124-4834545. #MonoclonalAntibodyTherapy #COVID19India #IndiaFightsCorona #Medanta | Medanta

Today NIH announced the launch of #ACTIV-2 (outpatient) Phase 2/3 and ACTIV-3 (inpatient) Phase 3 clinical trials investigating the use of monoclonal antibodies as a potential treatment for #COVID19. Antibodies are molecules our immune systems use to fight germs. People recovered from #COVID19 can produce antibodies. Researchers can examine blood samples from COVID-19 survivors & isolate antibodies. Scientists then create lab-engineered copies, thus making monoclonal antibodies. | National Insti

145K views | Reel by All About Molecular Biology